Trial intelligence / Profile preview

Cinnamon and Ginger Extracts vs Chlorhexidine for Oral Streptococcus Mutans

NCT03061916Phase 3Unknown

Sponsor
Cairo University
Start
Mar 2017
Primary completion
May 2017
Countries
1
01

Overview

Phase 3, randomised, single-blind trial (3 arms), sponsored by Cairo University. Primary endpoint: Viability count of Mutans Streptococci in saliva at 2 hours. Status: unknown.

Beyond the preview

Go deeper on NCT03061916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03061916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call